Bionano Genomics Equity Warrants Exp 21 Sep 2023 *W EXP 09/21/2023
Change company Symbol lookup
Select an option...
BNGOW Bionano Genomics Equity Warrants Exp 21 Sep 2023 *W EXP 09/21/2023
SWZ Swiss Helvetia Fund Inc
BALL Ball Corp
KIIIW Kismet Acquisition Three Equity Warrant Exp 30 June 2026 *W EXP 06/30/2026
SG Sweetgreen Inc
MAXN Maxeon Solar Technologies Ltd
PARAP Paramount Global
INT World Fuel Services Corp
NGD New Gold Inc
CRT Cross Timbers Royalty Trust
Go

Health Care : Life Sciences Tools & Services | Small Cap Value
Company profile

Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sell the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

Closing Price
$0.24
Day's Change
-0.0599 (-19.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.3434
Day's Low
0.24
Volume
(Heavy Day)
Volume:
16,721

10-day average volume:
11,252
16,721

Display:

Providers:

UpdateCancel
6 providers
June 29, 2022
Bionano Genomics Announces Issuance of a U.S. Patent for Analysis of Small Nucleic Acid Fragments in Nanochannel Arrays

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that the United States Patent and Trademark Office issued US Patent No.11,359,244 on June 14, 2022. The patent, titled "CHARACTERIZATION OF...(Globe Newswire)

June 16, 2022
Bionano Genomics Announces Participation at the European Association for Cancer Research (EACR) Congress 2022 Featuring OGM Applications for Cancer Research

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation at the European Association for Cancer Research (EACR) 2022 Congress with scientific and poster presentations highlighting the...(Globe Newswire)

June 10, 2022
Bionano Genomics Announces Participation at the European Society of Human Genetics Conference (ESHG) 2022 Featuring OGM Across a Broad Range of Clinical Research Applications and a Collaborative Product Development with Hamilton

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation at the European Society of Human Genetics (ESHG) 2022 Conference, with 13 scientific and poster presentations highlighting the...(Globe Newswire)

June 09, 2022
Hamilton and Bionano Genomics Announce World's First Ultra High Molecular Weight DNA Extraction Automation Solution for OGM

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END Hamilton and Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the collaborative development of the Long String VANTAGE for the isolation of Ultra High Molecular Weight (UHMW) DNA for use in...(Globe Newswire)

June 08, 2022
Bionano Genomics Announces Publication of a New Study Using OGM to Investigate Inversions that May Lead to Genetic Disorders

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyrsystem and provider of NxClinical(TM) software, the leading solution for visualization...(Globe Newswire)

June 03, 2022
Bionano Genomics Announces Canadian College of Medical Geneticists Presentation Featuring Applications of OGM for Genetic Research

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyrsystem and provider of NxClinical(TM) software, the leading solution for visualization...(Globe Newswire)

June 02, 2022
Bionano Genomics Announces Participation at the Advances in Genome Biology and Technology (AGBT) General Meeting 2022

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END -- Dr. Alka Chaubey, chief medical officer of Bionano, will present a spotlight session titled "OGM + NGS for Transforming Genome Biology: The Future is Bright!" (Globe Newswire)

May 26, 2022
Bionano Announces Glass Lewis Recommendation and Encourages Stockholders to Cast their Vote Ahead of June 9th Annual Meeting

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyrsystem and provider of NxClinical(TM) software, the leading solution for visualization...(Globe Newswire)

First Published Study of OGM in Pediatric AML Shows OGM Identifies MRD Markers and other Novel Variants that Can Impact Case Management

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyrsystem and provider of NxClinical(TM) software, the leading solution for visualization...(Globe Newswire)

May 17, 2022
Bionano Genomics to Present at the 2022 H.C. Wainwright Global Investment Conference

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr(R) system and provider of NxClinical(TM) software, the leading solution for visualization...(Globe Newswire)

May 13, 2022
Bionano Genomics Announces Participation at the 2022 American Cytogenomics Conference (ACC) and a User Spotlight Event at Augusta University, a Center of Excellence for OGM

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END -- Following the conference, Bionano will host a user spotlight event at an OGM center of excellence at the Georgia Esoteric Molecular Laboratory at Augusta University (Globe Newswire)

May 12, 2022
Bionano Genomics Announces a Publication From the First Affiliated Hospital of Zhengzhou Highlighting the Utility of OGM

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyrsystem and provider of NxClinical(TM) software, the leading solution for visualization...(Globe Newswire)

May 05, 2022
Bionano Genomics Reports First Quarter 2022 Financial Results and Highlights Recent Business Progress

EQNX::TICKER_START (NASDAQ:BNGO), EQNX::TICKER_END - 80% year-over-year revenue growth in Q1 2022 - Achieved all Q1 2022 ELEVATE! milestones - Strong balance sheet with $216.5 million in cash, cash equivalents, and available-for-sale securities at...(Globe Newswire)

April 29, 2022
Bionano Genomics Announces Peer-Reviewed Publication of NeuroSCORE Model to Predict and Prioritize Human Genes Contributing to Neurodevelopmental Disease

Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyrsystem and provider of NxClinical(TM) software, the leading solution for visualization, interpretation and reporting of genomic data, today...(Globe Newswire)

April 28, 2022
Bionano Genomics to Report First Quarter 2022 Financial Results and Host a Conference Call and Webcast on May 5, 2022

Bionano Genomics, Inc. (BNGO) today announced that it will host a conference call and live webcast on Thursday, May 5th, 2022 at 4:30 p.m. Eastern Time to report financial results for the first quarter 2022 and to highlight recent corporate...(Globe Newswire)

April 14, 2022
Bionano Genomics Announces Issuance of Two U.S. Patents for Novel Methods that Expand Patent Protection for Uses of Nanochannel Arrays in Genome Analysis

Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyrsystem and provider of NxClinical(TM) software, the leading solution for visualization, interpretation and reporting of genomic data, today...(Globe Newswire)

April 07, 2022
Bionano Genomics Announces Release of Version 6.2 of its NxClinical Software with Significant New Capabilities for Cancer Research Applications Including HRD Analysis

Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyrsystem and provider of NxClinical(TM) software, the leading solution for visualization, interpretation and reporting of genomic data, today announced the...(Globe Newswire)

April 06, 2022
Bionano Genomics Announces Publication of a New Study Using OGM Combined with Multiple Analytical Methods Including Single-Cell Analysis as a Comprehensive Molecular Strategy to Characterize the Genomic Variation in B-cell Acute Lymphoblastic Leukemia

Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyrsystem and provider of NxClinical(TM) software, the leading solution for visualization, interpretation and reporting of genomic data, today announced the...(Globe Newswire)

April 05, 2022
Bionano Genomics Announces Participation at the American Association for Cancer Research Annual Meeting Spotlighting Optical Genome Mapping Applications and Enhanced NxClinical Capabilities for Cancer Research

-- Bionano will exhibit all of its solutions relevant to cancer research: OGM systems, NxClinical software and expert laboratory services Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyrsystem and...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.